NO302899B1 - Rekombinant DNA-molekyl, transformert vertscelle, anvendelse av rekombinant DNA-molekyl og hybridvektor, og pektinlyasene PLA, PLB, PLC, PLE eller PLF i ren form - Google Patents

Rekombinant DNA-molekyl, transformert vertscelle, anvendelse av rekombinant DNA-molekyl og hybridvektor, og pektinlyasene PLA, PLB, PLC, PLE eller PLF i ren form Download PDF

Info

Publication number: NO302899B1
Authority: NO; Norway
Prior art keywords: dna molecule; recombinant dna; dsm; dna; pela
Prior art date: 1988-07-28

Application number

NO893063A

Other languages

English (en)

Norwegian (no)

Other versions

NO893063L (no

NO893063D0 (no

Inventor

Jutta Heim

Bernd Meyhack

Jacob Visser

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-07-28

Filing date

1989-07-27

Publication date

1998-05-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26294209&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO302899(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-07-28 Priority claimed from GB888818046A external-priority patent/GB8818046D0/en

1989-07-27 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1989-07-27 Publication of NO893063D0 publication Critical patent/NO893063D0/no

1990-01-29 Publication of NO893063L publication Critical patent/NO893063L/no

1998-05-04 Publication of NO302899B1 publication Critical patent/NO302899B1/no

Links

239000013598 vector Substances 0.000 title claims description 79
102000053602 DNA Human genes 0.000 title claims description 52
108020004511 Recombinant DNA Proteins 0.000 title claims description 42
239000012634 fragment Substances 0.000 claims description 124
108090000623 proteins and genes Proteins 0.000 claims description 120
239000013612 plasmid Substances 0.000 claims description 107
241000228245 Aspergillus niger Species 0.000 claims description 96
101150098295 pel1 gene Proteins 0.000 claims description 60
108010029182 Pectin lyase Proteins 0.000 claims description 45
108010076504 Protein Sorting Signals Proteins 0.000 claims description 40
108091028043 Nucleic acid sequence Proteins 0.000 claims description 32
108010050904 Interferons Proteins 0.000 claims description 27
102000014150 Interferons Human genes 0.000 claims description 27
229940079322 interferon Drugs 0.000 claims description 27
101150050446 pelB gene Proteins 0.000 claims description 26
101150114442 pelC gene Proteins 0.000 claims description 22
101100136076 Aspergillus oryzae (strain ATCC 42149 / RIB 40) pel1 gene Proteins 0.000 claims description 21
101150040383 pel2 gene Proteins 0.000 claims description 21
239000003550 marker Substances 0.000 claims description 19
241000228212 Aspergillus Species 0.000 claims description 17
238000002955 isolation Methods 0.000 claims description 16
101150100965 pel3 gene Proteins 0.000 claims description 16
108091092195 Intron Proteins 0.000 claims description 12
101150001047 pelE gene Proteins 0.000 claims description 12
101150061820 pelF gene Proteins 0.000 claims description 10
238000004519 manufacturing process Methods 0.000 claims description 9
230000002068 genetic effect Effects 0.000 claims description 7
230000001131 transforming effect Effects 0.000 claims description 6
230000006870 function Effects 0.000 claims description 3
238000012261 overproduction Methods 0.000 claims description 3
241001131785 Escherichia coli HB101 Species 0.000 claims 5
230000000717 retained effect Effects 0.000 claims 1
108020004414 DNA Proteins 0.000 description 140
101150108760 pelA gene Proteins 0.000 description 62
101100352566 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) plyB gene Proteins 0.000 description 53
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 53
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 49
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 44
102000004190 Enzymes Human genes 0.000 description 44
108090000790 Enzymes Proteins 0.000 description 44
229940088598 enzyme Drugs 0.000 description 44
101150056092 pelD gene Proteins 0.000 description 44
238000000034 method Methods 0.000 description 41
239000002609 medium Substances 0.000 description 38
238000009396 hybridization Methods 0.000 description 37
239000000203 mixture Substances 0.000 description 32
101100189842 Aspergillus oryzae (strain ATCC 42149 / RIB 40) pel2 gene Proteins 0.000 description 30
101710162447 Pectin lyase A Proteins 0.000 description 30
239000000523 sample Substances 0.000 description 30
108010052410 pectin lyase B Proteins 0.000 description 29
229920001277 pectin Polymers 0.000 description 28
239000011780 sodium chloride Substances 0.000 description 28
241000588724 Escherichia coli Species 0.000 description 27
239000000872 buffer Substances 0.000 description 27
210000004027 cell Anatomy 0.000 description 27
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 26
150000001413 amino acids Chemical group 0.000 description 26
239000001814 pectin Substances 0.000 description 26
235000010987 pectin Nutrition 0.000 description 26
101710162465 Pectin lyase D Proteins 0.000 description 25
239000002773 nucleotide Substances 0.000 description 25
125000003729 nucleotide group Chemical group 0.000 description 25
239000000243 solution Substances 0.000 description 24
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
108090000765 processed proteins & peptides Proteins 0.000 description 23
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 22
229920001817 Agar Polymers 0.000 description 21
239000008272 agar Substances 0.000 description 21
238000005119 centrifugation Methods 0.000 description 20
101001099437 Aspergillus niger Pectin lyase D Proteins 0.000 description 19
230000000694 effects Effects 0.000 description 19
235000018102 proteins Nutrition 0.000 description 19
102000004169 proteins and genes Human genes 0.000 description 19
241000233866 Fungi Species 0.000 description 18
101710161551 Pectate lyase 3 Proteins 0.000 description 18
101710124951 Phospholipase C Proteins 0.000 description 18
101710179609 Probable pectin lyase C Proteins 0.000 description 18
229920001184 polypeptide Polymers 0.000 description 18
102000004196 processed proteins & peptides Human genes 0.000 description 18
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 17
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 16
230000009466 transformation Effects 0.000 description 16
238000010367 cloning Methods 0.000 description 15
241000351920 Aspergillus nidulans Species 0.000 description 14
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 14
108091026890 Coding region Proteins 0.000 description 13
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 13
229940024606 amino acid Drugs 0.000 description 13
235000001014 amino acid Nutrition 0.000 description 13
239000000499 gel Substances 0.000 description 13
238000011534 incubation Methods 0.000 description 13
210000001938 protoplast Anatomy 0.000 description 13
101100523058 Aspergillus niger pyrG gene Proteins 0.000 description 12
108020004705 Codon Proteins 0.000 description 12
240000004808 Saccharomyces cerevisiae Species 0.000 description 12
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 12
239000011543 agarose gel Substances 0.000 description 12
229960000723 ampicillin Drugs 0.000 description 12
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 12
101150014229 carA gene Proteins 0.000 description 12
101150070764 carB gene Proteins 0.000 description 12
PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 12
239000007983 Tris buffer Substances 0.000 description 11
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 11
238000003776 cleavage reaction Methods 0.000 description 11
239000012153 distilled water Substances 0.000 description 11
230000007017 scission Effects 0.000 description 11
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 11
229940045145 uridine Drugs 0.000 description 11
239000003298 DNA probe Substances 0.000 description 10
238000006243 chemical reaction Methods 0.000 description 10
239000006166 lysate Substances 0.000 description 10
238000000746 purification Methods 0.000 description 10
238000012216 screening Methods 0.000 description 10
239000012064 sodium phosphate buffer Substances 0.000 description 10
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 10
108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
101001099542 Aspergillus niger Pectin lyase A Proteins 0.000 description 9
241000894006 Bacteria Species 0.000 description 9
238000004458 analytical method Methods 0.000 description 9
238000002474 experimental method Methods 0.000 description 9
238000000338 in vitro Methods 0.000 description 9
238000002360 preparation method Methods 0.000 description 9
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 8
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
108700007698 Genetic Terminator Regions Proteins 0.000 description 8
241000221961 Neurospora crassa Species 0.000 description 8
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
238000010276 construction Methods 0.000 description 8
239000000706 filtrate Substances 0.000 description 8
230000012010 growth Effects 0.000 description 8
239000007788 liquid Substances 0.000 description 8
239000001301 oxygen Substances 0.000 description 8
229910052760 oxygen Inorganic materials 0.000 description 8
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 8
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
108020004682 Single-Stranded DNA Proteins 0.000 description 7
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 7
229960005542 ethidium bromide Drugs 0.000 description 7
239000008103 glucose Substances 0.000 description 7
229910001629 magnesium chloride Inorganic materials 0.000 description 7
108020004999 messenger RNA Proteins 0.000 description 7
238000012163 sequencing technique Methods 0.000 description 7
239000000758 substrate Substances 0.000 description 7
ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 6
229920000936 Agarose Polymers 0.000 description 6
239000004475 Arginine Substances 0.000 description 6
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
239000000020 Nitrocellulose Substances 0.000 description 6
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 6
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
239000004098 Tetracycline Substances 0.000 description 6
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 6
210000004899 c-terminal region Anatomy 0.000 description 6
239000001110 calcium chloride Substances 0.000 description 6
235000011148 calcium chloride Nutrition 0.000 description 6
229910001628 calcium chloride Inorganic materials 0.000 description 6
238000012869 ethanol precipitation Methods 0.000 description 6
238000001914 filtration Methods 0.000 description 6
230000010354 integration Effects 0.000 description 6
244000005700 microbiome Species 0.000 description 6
231100000350 mutagenesis Toxicity 0.000 description 6
238000002703 mutagenesis Methods 0.000 description 6
229920001220 nitrocellulos Polymers 0.000 description 6
239000013615 primer Substances 0.000 description 6
108091008146 restriction endonucleases Proteins 0.000 description 6
239000000725 suspension Substances 0.000 description 6
229960002180 tetracycline Drugs 0.000 description 6
229930101283 tetracycline Natural products 0.000 description 6
235000019364 tetracycline Nutrition 0.000 description 6
150000003522 tetracyclines Chemical class 0.000 description 6
102000012410 DNA Ligases Human genes 0.000 description 5
108010061982 DNA Ligases Proteins 0.000 description 5
108700039691 Genetic Promoter Regions Proteins 0.000 description 5
108091034117 Oligonucleotide Proteins 0.000 description 5
101150049917 Pli gene Proteins 0.000 description 5
108010059820 Polygalacturonase Proteins 0.000 description 5
239000000427 antigen Substances 0.000 description 5
238000000211 autoradiogram Methods 0.000 description 5
230000001580 bacterial effect Effects 0.000 description 5
238000012512 characterization method Methods 0.000 description 5
238000001155 isoelectric focusing Methods 0.000 description 5
230000003505 mutagenic effect Effects 0.000 description 5
102000039446 nucleic acids Human genes 0.000 description 5
108020004707 nucleic acids Proteins 0.000 description 5
150000007523 nucleic acids Chemical class 0.000 description 5
230000036961 partial effect Effects 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 4
SEHFUALWMUWDKS-UHFFFAOYSA-N 5-fluoroorotic acid Chemical compound OC(=O)C=1NC(=O)NC(=O)C=1F SEHFUALWMUWDKS-UHFFFAOYSA-N 0.000 description 4
102000004594 DNA Polymerase I Human genes 0.000 description 4
108010017826 DNA Polymerase I Proteins 0.000 description 4
108020003215 DNA Probes Proteins 0.000 description 4
208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 4
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
238000002105 Southern blotting Methods 0.000 description 4
108091007433 antigens Proteins 0.000 description 4
102000036639 antigens Human genes 0.000 description 4
239000008346 aqueous phase Substances 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
238000007796 conventional method Methods 0.000 description 4
230000002950 deficient Effects 0.000 description 4
238000012217 deletion Methods 0.000 description 4
230000037430 deletion Effects 0.000 description 4
230000029087 digestion Effects 0.000 description 4
239000000284 extract Substances 0.000 description 4
238000000605 extraction Methods 0.000 description 4
239000011536 extraction buffer Substances 0.000 description 4
230000004927 fusion Effects 0.000 description 4
239000001963 growth medium Substances 0.000 description 4
230000001965 increasing effect Effects 0.000 description 4
230000001939 inductive effect Effects 0.000 description 4
150000002500 ions Chemical class 0.000 description 4
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
231100000219 mutagenic Toxicity 0.000 description 4
229910052757 nitrogen Inorganic materials 0.000 description 4
235000015097 nutrients Nutrition 0.000 description 4
239000008188 pellet Substances 0.000 description 4
239000000047 product Substances 0.000 description 4
101150089778 pyr-4 gene Proteins 0.000 description 4
101150054232 pyrG gene Proteins 0.000 description 4
239000001632 sodium acetate Substances 0.000 description 4
235000017281 sodium acetate Nutrition 0.000 description 4
239000006228 supernatant Substances 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
238000011144 upstream manufacturing Methods 0.000 description 4
238000005406 washing Methods 0.000 description 4
241001513093 Aspergillus awamori Species 0.000 description 3
241000125121 Aspergillus carbonarius Species 0.000 description 3
241001619326 Cephalosporium Species 0.000 description 3
108091035707 Consensus sequence Proteins 0.000 description 3
229920002271 DEAE-Sepharose Polymers 0.000 description 3
238000001712 DNA sequencing Methods 0.000 description 3
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 3
102100022624 Glucoamylase Human genes 0.000 description 3
108060003951 Immunoglobulin Proteins 0.000 description 3
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 3
AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 3
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 3
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 3
UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 3
239000008118 PEG 6000 Substances 0.000 description 3
229910019142 PO4 Inorganic materials 0.000 description 3
108090000445 Parathyroid hormone Proteins 0.000 description 3
241000228143 Penicillium Species 0.000 description 3
229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 3
108010059712 Pronase Proteins 0.000 description 3
102000003978 Tissue Plasminogen Activator Human genes 0.000 description 3
108090000373 Tissue Plasminogen Activator Proteins 0.000 description 3
241000700605 Viruses Species 0.000 description 3
238000002835 absorbance Methods 0.000 description 3
230000003321 amplification Effects 0.000 description 3
101150008194 argB gene Proteins 0.000 description 3
-1 aromatic amino acids Chemical class 0.000 description 3
230000003115 biocidal effect Effects 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
239000013611 chromosomal DNA Substances 0.000 description 3
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 3
238000000502 dialysis Methods 0.000 description 3
108010052305 exodeoxyribonuclease III Proteins 0.000 description 3
108010093305 exopolygalacturonase Proteins 0.000 description 3
239000013604 expression vector Substances 0.000 description 3
235000013305 food Nutrition 0.000 description 3
238000010353 genetic engineering Methods 0.000 description 3
230000002209 hydrophobic effect Effects 0.000 description 3
102000018358 immunoglobulin Human genes 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
238000013507 mapping Methods 0.000 description 3
238000002844 melting Methods 0.000 description 3
230000035772 mutation Effects 0.000 description 3
238000010899 nucleation Methods 0.000 description 3
238000003199 nucleic acid amplification method Methods 0.000 description 3
230000003287 optical effect Effects 0.000 description 3
229960003104 ornithine Drugs 0.000 description 3
238000004806 packaging method and process Methods 0.000 description 3
150000002989 phenols Chemical class 0.000 description 3
239000010452 phosphate Substances 0.000 description 3
229920001223 polyethylene glycol Polymers 0.000 description 3
239000002244 precipitate Substances 0.000 description 3
230000008569 process Effects 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
230000010076 replication Effects 0.000 description 3
230000028327 secretion Effects 0.000 description 3
238000010561 standard procedure Methods 0.000 description 3
229960000187 tissue plasminogen activator Drugs 0.000 description 3
231100000331 toxic Toxicity 0.000 description 3
230000002588 toxic effect Effects 0.000 description 3
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
RSZXXBTXZJGELH-UHFFFAOYSA-N 2,3,4-tri(propan-2-yl)naphthalene-1-sulfonic acid Chemical compound C1=CC=CC2=C(C(C)C)C(C(C)C)=C(C(C)C)C(S(O)(=O)=O)=C21 RSZXXBTXZJGELH-UHFFFAOYSA-N 0.000 description 2
WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 2
FHIDNBAQOFJWCA-UAKXSSHOSA-N 5-fluorouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 FHIDNBAQOFJWCA-UAKXSSHOSA-N 0.000 description 2
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
108010051457 Acid Phosphatase Proteins 0.000 description 2
108010039209 Blood Coagulation Factors Proteins 0.000 description 2
102000015081 Blood Coagulation Factors Human genes 0.000 description 2
102000055006 Calcitonin Human genes 0.000 description 2
108060001064 Calcitonin Proteins 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
108090000489 Carboxy-Lyases Proteins 0.000 description 2
108091033380 Coding strand Proteins 0.000 description 2
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
238000007399 DNA isolation Methods 0.000 description 2
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
241001524679 Escherichia virus M13 Species 0.000 description 2
108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
241000700721 Hepatitis B virus Species 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 2
102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 2
108010047761 Interferon-alpha Proteins 0.000 description 2
102000006992 Interferon-alpha Human genes 0.000 description 2
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
239000004472 Lysine Substances 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
238000000636 Northern blotting Methods 0.000 description 2
101710163270 Nuclease Proteins 0.000 description 2
108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 description 2
108020002230 Pancreatic Ribonuclease Proteins 0.000 description 2
102000005891 Pancreatic ribonuclease Human genes 0.000 description 2
102100036893 Parathyroid hormone Human genes 0.000 description 2
244000100170 Phaseolus lunatus Species 0.000 description 2
235000010617 Phaseolus lunatus Nutrition 0.000 description 2
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
241000276498 Pollachius virens Species 0.000 description 2
101100370749 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) trpC1 gene Proteins 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
239000004473 Threonine Substances 0.000 description 2
108010009583 Transforming Growth Factors Proteins 0.000 description 2
102000009618 Transforming Growth Factors Human genes 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
241000711975 Vesicular stomatitis virus Species 0.000 description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
239000002253 acid Substances 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
230000004913 activation Effects 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
101150069003 amdS gene Proteins 0.000 description 2
229960004909 aminosalicylic acid Drugs 0.000 description 2
238000005571 anion exchange chromatography Methods 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
239000003114 blood coagulation factor Substances 0.000 description 2
229960004015 calcitonin Drugs 0.000 description 2
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 2
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
239000007857 degradation product Substances 0.000 description 2
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
108010031145 eglin proteinase inhibitors Proteins 0.000 description 2
DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
239000000945 filler Substances 0.000 description 2
239000011491 glass wool Substances 0.000 description 2
230000013595 glycosylation Effects 0.000 description 2
238000006206 glycosylation reaction Methods 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
239000000122 growth hormone Substances 0.000 description 2
230000003301 hydrolyzing effect Effects 0.000 description 2
MSQACBWWAIBWIC-UHFFFAOYSA-N hydron;piperazine;chloride Chemical compound Cl.C1CNCCN1 MSQACBWWAIBWIC-UHFFFAOYSA-N 0.000 description 2
229940072221 immunoglobulins Drugs 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
238000009776 industrial production Methods 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
229940047124 interferons Drugs 0.000 description 2
101150066555 lacZ gene Proteins 0.000 description 2
230000003902 lesion Effects 0.000 description 2
238000009630 liquid culture Methods 0.000 description 2
238000006977 lyase reaction Methods 0.000 description 2
239000000463 material Substances 0.000 description 2
230000008018 melting Effects 0.000 description 2
210000004898 n-terminal fragment Anatomy 0.000 description 2
108010090409 novozym 234 Proteins 0.000 description 2
101150008001 pl gene Proteins 0.000 description 2
238000007747 plating Methods 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
239000000843 powder Substances 0.000 description 2
101150094562 qa-2 gene Proteins 0.000 description 2
230000004044 response Effects 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
230000001568 sexual effect Effects 0.000 description 2
230000037432 silent mutation Effects 0.000 description 2
238000002741 site-directed mutagenesis Methods 0.000 description 2
239000007974 sodium acetate buffer Substances 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
101150118377 tet gene Proteins 0.000 description 2
238000004448 titration Methods 0.000 description 2
230000005030 transcription termination Effects 0.000 description 2
101150016309 trpC gene Proteins 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 2
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
238000001262 western blot Methods 0.000 description 2
GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
MLONYBFKXHEPCD-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(N)(CO)CO.OCC(N)(CO)CO MLONYBFKXHEPCD-UHFFFAOYSA-N 0.000 description 1
BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
LVSPDZAGCBEQAV-UHFFFAOYSA-N 4-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=CC=C(Cl)C2=C1 LVSPDZAGCBEQAV-UHFFFAOYSA-N 0.000 description 1
102000013563 Acid Phosphatase Human genes 0.000 description 1
108091005508 Acid proteases Proteins 0.000 description 1
102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 1
102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
102100021253 Antileukoproteinase Human genes 0.000 description 1
240000006439 Aspergillus oryzae Species 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
101150076489 B gene Proteins 0.000 description 1
238000000035 BCA protein assay Methods 0.000 description 1
101100007857 Bacillus subtilis (strain 168) cspB gene Proteins 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
101150111062 C gene Proteins 0.000 description 1
101100427576 Caenorhabditis elegans ung-1 gene Proteins 0.000 description 1
241000283707 Capra Species 0.000 description 1
101710132601 Capsid protein Proteins 0.000 description 1
102000004031 Carboxy-Lyases Human genes 0.000 description 1
235000005979 Citrus limon Nutrition 0.000 description 1
244000131522 Citrus pyriformis Species 0.000 description 1
102100022641 Coagulation factor IX Human genes 0.000 description 1
AEMOLEFTQBMNLQ-DTEWXJGMSA-N D-Galacturonic acid Natural products O[C@@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-DTEWXJGMSA-N 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108090000204 Dipeptidase 1 Proteins 0.000 description 1
ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
102400001368 Epidermal growth factor Human genes 0.000 description 1
101800003838 Epidermal growth factor Proteins 0.000 description 1
102000003951 Erythropoietin Human genes 0.000 description 1
108090000394 Erythropoietin Proteins 0.000 description 1
241000701959 Escherichia virus Lambda Species 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
108700024394 Exon Proteins 0.000 description 1
108010076282 Factor IX Proteins 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
108020000949 Fungal DNA Proteins 0.000 description 1
108010093031 Galactosidases Proteins 0.000 description 1
102000002464 Galactosidases Human genes 0.000 description 1
IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
101150009006 HIS3 gene Proteins 0.000 description 1
101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 1
206010019786 Hepatitis non-A non-B Diseases 0.000 description 1
241000709721 Hepatovirus A Species 0.000 description 1
102000007625 Hirudins Human genes 0.000 description 1
108010007267 Hirudins Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000615334 Homo sapiens Antileukoproteinase Proteins 0.000 description 1
101000741445 Homo sapiens Calcitonin Proteins 0.000 description 1
101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
102100037852 Insulin-like growth factor I Human genes 0.000 description 1
108010078049 Interferon alpha-2 Proteins 0.000 description 1
102100040018 Interferon alpha-2 Human genes 0.000 description 1
102000003996 Interferon-beta Human genes 0.000 description 1
108090000467 Interferon-beta Proteins 0.000 description 1
108010002352 Interleukin-1 Proteins 0.000 description 1
102000000589 Interleukin-1 Human genes 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
102000000588 Interleukin-2 Human genes 0.000 description 1
102100039064 Interleukin-3 Human genes 0.000 description 1
108010002386 Interleukin-3 Proteins 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 1
101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
241000446313 Lamella Species 0.000 description 1
108091036060 Linker DNA Proteins 0.000 description 1
102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
102000009151 Luteinizing Hormone Human genes 0.000 description 1
108010073521 Luteinizing Hormone Proteins 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
239000000637 Melanocyte-Stimulating Hormone Substances 0.000 description 1
108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 1
KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
230000004988 N-glycosylation Effects 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
108010025020 Nerve Growth Factor Proteins 0.000 description 1
102000015336 Nerve Growth Factor Human genes 0.000 description 1
101100444142 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) dut-1 gene Proteins 0.000 description 1
102000007981 Ornithine carbamoyltransferase Human genes 0.000 description 1
101710113020 Ornithine transcarbamylase, mitochondrial Proteins 0.000 description 1
102100037214 Orotidine 5'-phosphate decarboxylase Human genes 0.000 description 1
102000003982 Parathyroid hormone Human genes 0.000 description 1
101710093028 Pectate trisaccharide-lyase Proteins 0.000 description 1
102000015731 Peptide Hormones Human genes 0.000 description 1
108010038988 Peptide Hormones Proteins 0.000 description 1
101000972349 Phytolacca americana Lectin-A Proteins 0.000 description 1
108020005089 Plant RNA Proteins 0.000 description 1
108010001014 Plasminogen Activators Proteins 0.000 description 1
102000001938 Plasminogen Activators Human genes 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
241000053208 Porcellio laevis Species 0.000 description 1
102100027467 Pro-opiomelanocortin Human genes 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
108020005115 Pyruvate Kinase Proteins 0.000 description 1
102000003743 Relaxin Human genes 0.000 description 1
108090000103 Relaxin Proteins 0.000 description 1
108090000783 Renin Proteins 0.000 description 1
102100028255 Renin Human genes 0.000 description 1
101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
108020001027 Ribosomal DNA Proteins 0.000 description 1
108010086019 Secretin Proteins 0.000 description 1
102100037505 Secretin Human genes 0.000 description 1
241000702208 Shigella phage SfX Species 0.000 description 1
102000013275 Somatomedins Human genes 0.000 description 1
102000005157 Somatostatin Human genes 0.000 description 1
108010056088 Somatostatin Proteins 0.000 description 1
235000019764 Soybean Meal Nutrition 0.000 description 1
108010039445 Stem Cell Factor Proteins 0.000 description 1
101000879712 Streptomyces lividans Protease inhibitor Proteins 0.000 description 1
102000019197 Superoxide Dismutase Human genes 0.000 description 1
108010012715 Superoxide dismutase Proteins 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
108020004440 Thymidine kinase Proteins 0.000 description 1
108010046075 Thymosin Proteins 0.000 description 1
102000007501 Thymosin Human genes 0.000 description 1
101100354953 Treponema denticola (strain ATCC 35405 / DSM 14222 / CIP 103919 / JCM 8153 / KCTC 15104) pyrBI gene Proteins 0.000 description 1
239000007984 Tris EDTA buffer Substances 0.000 description 1
108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 description 1
FOGRQMPFHUHIGU-UHFFFAOYSA-N Uridylic acid Natural products OC1C(OP(O)(O)=O)C(CO)OC1N1C(=O)NC(=O)C=C1 FOGRQMPFHUHIGU-UHFFFAOYSA-N 0.000 description 1
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
108700040099 Xylose isomerases Proteins 0.000 description 1
CTCBPRXHVPZNHB-VQFZJOCSSA-N [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate;(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O.C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O CTCBPRXHVPZNHB-VQFZJOCSSA-N 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
108090000637 alpha-Amylases Proteins 0.000 description 1
102000004139 alpha-Amylases Human genes 0.000 description 1
229940024171 alpha-amylase Drugs 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000259 anti-tumor effect Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
229940019748 antifibrinolytic proteinase inhibitors Drugs 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
229940009098 aspartate Drugs 0.000 description 1
GOOXRYWLNNXLFL-UHFFFAOYSA-H azane oxygen(2-) ruthenium(3+) ruthenium(4+) hexachloride Chemical compound N.N.N.N.N.N.N.N.N.N.N.N.N.N.[O--].[O--].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Ru+3].[Ru+3].[Ru+4] GOOXRYWLNNXLFL-UHFFFAOYSA-H 0.000 description 1
230000008901 benefit Effects 0.000 description 1
AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
108010042362 beta-Lipotropin Proteins 0.000 description 1
102000006635 beta-lactamase Human genes 0.000 description 1
229940019700 blood coagulation factors Drugs 0.000 description 1
238000009835 boiling Methods 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
210000004900 c-terminal fragment Anatomy 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
244000309466 calf Species 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
229940040387 citrus pectin Drugs 0.000 description 1
239000009194 citrus pectin Substances 0.000 description 1
238000005352 clarification Methods 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
230000001143 conditioned effect Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
101150110403 cspA gene Proteins 0.000 description 1
101150068339 cspLA gene Proteins 0.000 description 1
238000012786 cultivation procedure Methods 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
238000012258 culturing Methods 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
210000000172 cytosol Anatomy 0.000 description 1
238000006114 decarboxylation reaction Methods 0.000 description 1
238000000432 density-gradient centrifugation Methods 0.000 description 1
229940009976 deoxycholate Drugs 0.000 description 1
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000008021 deposition Effects 0.000 description 1
FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
229940079919 digestives enzyme preparation Drugs 0.000 description 1
239000013024 dilution buffer Substances 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
230000005611 electricity Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
239000012149 elution buffer Substances 0.000 description 1
YERABYSOHUZTPQ-UHFFFAOYSA-P endo-1,4-beta-Xylanase Chemical compound C=1C=CC=CC=1C[N+](CC)(CC)CCCNC(C(C=1)=O)=CC(=O)C=1NCCC[N+](CC)(CC)CC1=CC=CC=C1 YERABYSOHUZTPQ-UHFFFAOYSA-P 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
229940116977 epidermal growth factor Drugs 0.000 description 1
239000006167 equilibration buffer Substances 0.000 description 1
229940105423 erythropoietin Drugs 0.000 description 1
230000032050 esterification Effects 0.000 description 1
238000005886 esterification reaction Methods 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
229960004222 factor ix Drugs 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
235000015203 fruit juice Nutrition 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
239000011876 fused mixture Substances 0.000 description 1
238000011331 genomic analysis Methods 0.000 description 1
230000002518 glial effect Effects 0.000 description 1
229930195712 glutamate Natural products 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
229940006607 hirudin Drugs 0.000 description 1
WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940045644 human calcitonin Drugs 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
108010008429 immunoglobulin-binding factors Proteins 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
229960000318 kanamycin Drugs 0.000 description 1
229930027917 kanamycin Natural products 0.000 description 1
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
229930182823 kanamycin A Natural products 0.000 description 1
238000002372 labelling Methods 0.000 description 1
238000013493 large scale plasmid preparation Methods 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
229940040129 luteinizing hormone Drugs 0.000 description 1
101150039489 lysZ gene Proteins 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
230000001617 migratory effect Effects 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
239000003471 mutagenic agent Substances 0.000 description 1
231100000707 mutagenic chemical Toxicity 0.000 description 1
108010001078 naringinase Proteins 0.000 description 1
230000005709 nerve cell growth Effects 0.000 description 1
229940053128 nerve growth factor Drugs 0.000 description 1
229940046166 oligodeoxynucleotide Drugs 0.000 description 1
229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
231100000590 oncogenic Toxicity 0.000 description 1
230000002246 oncogenic effect Effects 0.000 description 1
238000012856 packing Methods 0.000 description 1
239000000199 parathyroid hormone Substances 0.000 description 1
229960001319 parathyroid hormone Drugs 0.000 description 1
230000037361 pathway Effects 0.000 description 1
108010087558 pectate lyase Proteins 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
150000008300 phosphoramidites Chemical class 0.000 description 1
229940127126 plasminogen activator Drugs 0.000 description 1
101150066372 pld gene Proteins 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920000053 polysorbate 80 Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000013641 positive control Substances 0.000 description 1
235000011056 potassium acetate Nutrition 0.000 description 1
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
101150098691 pyrB gene Proteins 0.000 description 1
239000011535 reaction buffer Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
238000004153 renaturation Methods 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
238000007363 ring formation reaction Methods 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
229920006298 saran Polymers 0.000 description 1
229960002101 secretin Drugs 0.000 description 1
OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
238000010187 selection method Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
230000011664 signaling Effects 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Inorganic materials [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
229940048086 sodium pyrophosphate Drugs 0.000 description 1
239000007787 solid Substances 0.000 description 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
229960000553 somatostatin Drugs 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
239000004455 soybean meal Substances 0.000 description 1
230000028070 sporulation Effects 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000009897 systematic effect Effects 0.000 description 1
238000012360 testing method Methods 0.000 description 1
235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
108010008268 transforming growth factor type e Proteins 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
101150108727 trpl gene Proteins 0.000 description 1
239000002753 trypsin inhibitor Substances 0.000 description 1
102000003390 tumor necrosis factor Human genes 0.000 description 1
230000007306 turnover Effects 0.000 description 1
238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
229960005356 urokinase Drugs 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
239000004474 valine Substances 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
235000015099 wheat brans Nutrition 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Mycology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Enzymes And Modification Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO893063A 1988-07-28 1989-07-27 Rekombinant DNA-molekyl, transformert vertscelle, anvendelse av rekombinant DNA-molekyl og hybridvektor, og pektinlyasene PLA, PLB, PLC, PLE eller PLF i ren form NO302899B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB888818046A GB8818046D0 (en)	1988-07-28	1988-07-28	New expression system
GB898914666A GB8914666D0 (en)	1988-07-28	1989-06-26	Novel expression system

Publications (3)

Publication Number	Publication Date
NO893063D0 NO893063D0 (no)	1989-07-27
NO893063L NO893063L (no)	1990-01-29
NO302899B1 true NO302899B1 (no)	1998-05-04

Family

ID=26294209

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO893063A NO302899B1 (no)	1988-07-28	1989-07-27	Rekombinant DNA-molekyl, transformert vertscelle, anvendelse av rekombinant DNA-molekyl og hybridvektor, og pektinlyasene PLA, PLB, PLC, PLE eller PLF i ren form

Country Status (14)

Country	Link
EP (1)	EP0353188B2 (da)
JP (1)	JP3009679B2 (da)
AU (1)	AU633012B2 (da)
CA (1)	CA1338859C (da)
DE (1)	DE68913846T3 (da)
DK (1)	DK175534B1 (da)
ES (1)	ES2063162T5 (da)
FI (1)	FI104637B (da)
HU (1)	HU212832B (da)
IE (1)	IE61871B1 (da)
IL (1)	IL91111A (da)
NO (1)	NO302899B1 (da)
NZ (1)	NZ230077A (da)
PT (1)	PT91286B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5298405A (en) *	1986-04-30	1994-03-29	Alko Limited	Enzyme preparations with recombinantly-altered cellulose profiles and methods for their production
GB8702475D0 (en) *	1987-02-04	1987-03-11	Ciba Geigy Ag	Expression system
JPH07503861A (ja) *	1992-12-24	1995-04-27	ギスト　ブロカデス　ナムローゼ　フェンノートシャップ	アスペルギルスからのエキソ−ポリガラクツロナーゼ遺伝子のクローニングと発現
US5858760A (en) *	1993-02-16	1999-01-12	Novo Nordisk A/S	Enzyme with pectin lyase activity
US5674728A (en) *	1993-11-03	1997-10-07	Novartis Corporation	Aspergillus niger vacuolar aspartyl protease
AU2660397A (en) *	1996-04-05	1997-10-29	Board Of Regents, The University Of Texas System	Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
US6083715A (en) *	1997-06-09	2000-07-04	Board Of Regents, The University Of Texas System	Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
CN102292437B (zh)	2008-12-19	2015-06-24	杜邦营养生物科学有限公司	生产酶产品的方法
EP2492343B1 (en) *	2009-10-19	2015-05-27	Bio-I Co., Ltd	Pectin lyase, pectin lyase gene, enzyme preparation, and method for production of single cells of plant tissue
CN104837991A (zh)	2012-08-16	2015-08-12	孟加拉朱特研究所	来自菜豆壳球孢菌的果胶降解酶及其用途
CN106635846B (zh) *	2016-12-28	2019-11-08	青岛蔚蓝生物集团有限公司	一种高产果胶甲酯酶的黑曲霉菌株
WO2018127486A1 (en)	2017-01-03	2018-07-12	Novozymes A/S	Enzymatic dehusking of pulses
WO2020002574A1 (en) *	2018-06-28	2020-01-02	Novozymes A/S	Enzymatic processing of sugar beets

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE253119T1 (de) *	1985-04-15	2003-11-15	Dsm Ip Assets Bv	Verwendung des glucoamylasepromotors aus apergillus
JPS63146790A (ja) *	1986-12-06	1988-06-18	Shizuoka Pref Gov	ペクチン酸リア−ゼの製造法
GB8702475D0 (en) *	1987-02-04	1987-03-11	Ciba Geigy Ag	Expression system

1989
- 1989-07-19 EP EP89810545A patent/EP0353188B2/en not_active Expired - Lifetime
- 1989-07-19 DE DE68913846T patent/DE68913846T3/de not_active Expired - Lifetime
- 1989-07-19 ES ES89810545T patent/ES2063162T5/es not_active Expired - Lifetime
- 1989-07-24 FI FI893541A patent/FI104637B/fi active IP Right Grant
- 1989-07-25 NZ NZ230077A patent/NZ230077A/en unknown
- 1989-07-26 CA CA000606648A patent/CA1338859C/en not_active Expired - Lifetime
- 1989-07-26 PT PT91286A patent/PT91286B/pt not_active IP Right Cessation
- 1989-07-26 IL IL9111189A patent/IL91111A/en unknown
- 1989-07-27 HU HU893823A patent/HU212832B/hu unknown
- 1989-07-27 IE IE244789A patent/IE61871B1/en not_active IP Right Cessation
- 1989-07-27 AU AU39062/89A patent/AU633012B2/en not_active Expired
- 1989-07-27 NO NO893063A patent/NO302899B1/no not_active IP Right Cessation
- 1989-07-27 JP JP1192813A patent/JP3009679B2/ja not_active Expired - Lifetime
- 1989-07-27 DK DK198903709A patent/DK175534B1/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE68913846T3 (de)	2002-10-02
DK370989A (da)	1990-01-29
FI104637B (fi)	2000-03-15
DK175534B1 (da)	2004-11-22
EP0353188B1 (en)	1994-03-16
HU212832B (en)	1996-12-30
DE68913846D1 (de)	1994-04-21
ES2063162T3 (es)	1995-01-01
NO893063L (no)	1990-01-29
PT91286A (pt)	1990-02-08
DE68913846T2 (de)	1994-07-14
CA1338859C (en)	1997-01-21
FI893541A0 (fi)	1989-07-24
IE892447L (en)	1990-01-28
JPH03108487A (ja)	1991-05-08
IL91111A0 (en)	1990-03-19
NZ230077A (en)	1992-04-28
EP0353188B2 (en)	2002-03-06
FI893541A (fi)	1990-01-29
AU3906289A (en)	1990-02-01
ES2063162T5 (es)	2002-11-16
AU633012B2 (en)	1993-01-21
PT91286B (pt)	1995-03-01
IE61871B1 (en)	1994-11-30
HUT51333A (en)	1990-04-28
NO893063D0 (no)	1989-07-27
EP0353188A2 (en)	1990-01-31
DK370989D0 (da)	1989-07-27
EP0353188A3 (en)	1990-10-03
JP3009679B2 (ja)	2000-02-14
IL91111A (en)	1995-07-31

Legal Events

Date	Code	Title	Description
2009-08-31	MK1K	Patent expired

Publication	Publication Date	Title
US7517668B1 (en)	2009-04-14	Process for the production of protein products in aspergillus
US5863759A (en)	1999-01-26	Process for the production of protein products in aspergillus
JP3005618B2 (ja)	2000-01-31	アスペルギルス属酵母のプロモーター
EP0096430A1 (en)	1983-12-21	Cloning system for Kluyveromyces species
US5874558A (en)	1999-02-23	Nucleic acid encoding a recombinant humicola sp. lipase
JPS6156092A (ja)	1986-03-20	安定なｄｎａ構成物
FI105484B (fi)	2000-08-31	Pektiinilyaasin ilmentämisjärjestelmää koodittava yhdistelmä-DNA-molekyyli
NO302899B1 (no)	1998-05-04	Rekombinant DNA-molekyl, transformert vertscelle, anvendelse av rekombinant DNA-molekyl og hybridvektor, og pektinlyasene PLA, PLB, PLC, PLE eller PLF i ren form
US5447862A (en)	1995-09-05	Pectin lyase genes of aspergillus niger
EP0439997B1 (en)	1995-11-08	Novel fungal expression system
JPH06343471A (ja)	1994-12-20	ポリペプチドの製造方法
KR0166956B1 (ko)	1999-01-15	펙틴 리아제의 발현 시스템을 암호화하는 재조합 dna분자
NZ219435A (en)	1988-01-08	Production of glucoamylase by recombinant techniques